Margreet G E M Ausems (Margreet G Ausems)

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 18

Top Topics

Radical Prostatectomy

Endoplasmic Reticulum

Top Venues

Familial cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Danny Bruins, Suzanne M Onstwedder, Martina Cornelia Cornel, Margreet G E M Ausems, Marc H W van Mil, Tessel Rigter
Information Provision Regarding Health-Related Direct-to-Consumer Genetic Testing for Dutch Consumers: An in-Depth Content Analysis of Sellers' Websites. Genes 15 (4) (2024)
Danny Bruins, Suzanne M Onstwedder, Martina Cornelia Cornel, Margreet G E M Ausems, Marc H W van Mil, Tessel Rigter
Information Provision Regarding Health-Related Direct-to-Consumer Genetic Testing for Dutch Consumers: An in-Depth Content Analysis of Sellers' Websites. Genes 15 (4) (2024)
Danny Bruins, Suzanne M Onstwedder, Martina Cornelia Cornel, Margreet G E M Ausems, Marc H W van Mil, Tessel Rigter
Information Provision Regarding Health-Related Direct-to-Consumer Genetic Testing for Dutch Consumers: An in-Depth Content Analysis of Sellers' Websites. Genes 15 (4) (2024)
Iris A S Stroot, Jan Brouwer, Joost Bart, Harry Hollema, Denise J Stommel-Jenner, Marise M Wagner, H Lena C van Doorn, Joanne A de Hullu, Katja N Gaarenstroom, Marc Beurden, Luc R C W van Lonkhuijzen, Brigitte F M Slangen, Ronald P Zweemer, Encarna B Gómez-García, Margreet G E M Ausems, Ingrid A Boere, Klaartje van Engelen, Christi J van Asperen, Marjanka K Schmidt, Marijke R Wevers, Geertruida H de Bock, Marian J E Mourits, null null
High-Grade Serous Carcinoma at Risk-Reducing Salpingo-Oophorectomy in Asymptomatic Carriers of BRCA1/2 Pathogenic Variants: Prevalence and Clinical Factors. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Michiel Vlaming, Eveline M A Bleiker, Inge M van Oort, Lambertus A L M Kiemeney, Margreet G E M Ausems
Mainstream germline genetic testing in men with metastatic prostate cancer: design and protocol for a multicenter observational study. BMC cancer 22 (1) (2022)
Susana I S Patuleia, Cathy B Moelans, Jasmijn Koopman, Julia E C van Steenhoven, Thijs van Dalen, Carmen C van der Pol, Agnes Jager, Margreet G E M Ausems, Paul J van Diest, Elsken van der Wall, Karlijn P M Suijkerbuijk
Patient-centered research: how do women tolerate nipple fluid aspiration as a potential screening tool for breast cancer? BMC cancer 22 (1) (2022)
Vera M Witjes, Jozé C C Braspenning, Nicoline Hoogerbrugge, Yvonne H C M Smolders, Dorien M A Hermkens, Marian J E Mourits, Marjolijn J L Ligtenberg, Margreet G E M Ausems, Joanne A de Hullu
Healthcare professionals' perspectives on implementation of universal tumor DNA testing in ovarian cancer patients: multidisciplinary focus groups. Familial cancer (2022)
Michiel Vlaming, Eveline M A Bleiker, Inge M van Oort, Lambertus A L M Kiemeney, Margreet G E M Ausems
Mainstream germline genetic testing in men with metastatic prostate cancer: design and protocol for a multicenter observational study. BMC cancer 22 (1) (2022)
Martine Dumont, Nana Weber-Lassalle, Charles Joly-Beauparlant, Corinna Ernst, Arnaud Droit, Bing-Jian Feng, Stéphane Dubois, Annie-Claude Collin-Deschesnes, Penny Soucy, Maxime Vallée, Frédéric Fournier, Audrey Lemaçon, Muriel A Adank, Jamie Allen, Janine Altmüller, Norbert Arnold, Margreet G E M Ausems, Riccardo Berutti, Manjeet K Bolla, Shelley B Bull, Sara Carvalho, Sten Cornelissen, Michael R Dufault, Alison M Dunning, Christoph Engel, Andrea Gehrig, Willemina R R Geurts-Giele, Christian Gieger, Jessica Green, Karl Hackmann, Mohamed Helmy, Julia Hentschel, Frans B L Hogervorst, Antoinette Hollestelle, Maartje J Hooning, Judit Horváth, M Arfan Ikram, Silke Kaulfuß, Renske Keeman, Da Kuang, Craig Luccarini, Wolfgang Maier, John W M Martens, Dieter Niederacher, Peter Nürnberg, Claus-Eric Ott, Annette Peters, Paul D P Pharoah, Alfredo Ramirez, Juliane Ramser, Steffi Riedel-Heller, Gunnar Schmidt, Mitul Shah, Martin Scherer, Antje Stäbler, Tim M Strom, Christian Sutter, Holger Thiele, Christi J van Asperen, Lizet van der Kolk, Rob B van der Luijt, Alexander E Volk, Michael Wagner, Quinten Waisfisz, Qin Wang, Shan Wang-Gohrke, Bernhard Heinrich Friedrich Weber, null Genome Of The Netherlands Project, null Ghs Study Group, Peter Devilee, Sean Tavtigian, Gary D Baider, Alfons Meindl, David E Goldgar, Irene L Andrulis, Rita K Schmutzler, Douglas F Easton, Marjanka K Schmidt, Eric Hahnen, Jacques Simard
Uncovering the Contribution of Moderate-Penetrance Susceptibility Genes to Breast Cancer by Whole-Exome Sequencing and Targeted Enrichment Sequencing of Candidate Genes in Women of European Ancestry. Cancers 14 (14) (2022)
Kyra Bokkers, Michiel Vlaming, Ellen G Engelhardt, Ronald P Zweemer, Inge M van Oort, Lambertus A L M Kiemeney, Eveline M A Bleiker, Margreet G E M Ausems
The Feasibility of Implementing Mainstream Germline Genetic Testing in Routine Cancer Care-A Systematic Review. Cancers 14 (4) (2022)
Michiel Vlaming, Eveline M A Bleiker, Inge M van Oort, Lambertus A L M Kiemeney, Margreet G E M Ausems
Mainstream germline genetic testing in men with metastatic prostate cancer: design and protocol for a multicenter observational study. BMC cancer 22 (1) (2022)
Michiel Vlaming, Eveline M A Bleiker, Inge M van Oort, Lambertus A L M Kiemeney, Margreet G E M Ausems
Mainstream germline genetic testing in men with metastatic prostate cancer: design and protocol for a multicenter observational study. BMC cancer 22 (1) (2022)
Kyra Bokkers, Ronald P Zweemer, Marco J Koudijs, Sanne Stehouwer, Mary E Velthuizen, Eveline M A Bleiker, Margreet G E M Ausems
Positive experiences of healthcare professionals with a mainstreaming approach of germline genetic testing for women with ovarian cancer. Familial cancer (2021)
Lara Terra, Maartje J Hooning, Bernadette Anna Maria Heemskerk-Gerritsen, M van Beurden, Jeanine E Roeters van Lennep, H Lena C van Doorn, Joanne A de Hullu, Constantijne H Mom, Eleonora B L van Dorst, Marian J E Mourits, Brigitte F M Slangen, Katja N Gaarenstroom, M Carola Zillikens, Tim Leiner, Lizet van der Kolk, J Margriet Collée, Marijke R Wevers, Margreet G E M Ausems, Klaartje van Engelen, Lieke Pv Berger, Christi J van Asperen, Encarna B Gómez-García, Irma van de Beek, Matti A Rookus, Michael Hauptmann, Eveline M A Bleiker, Sanne B Schagen, Neil K Aaronson, Angela H E M Maas, Flora E van Leeuwen
Long-Term Morbidity and Health After Early Menopause Due to Oophorectomy in Women at Increased Risk of Ovarian Cancer: Protocol for a Nationwide Cross-Sectional Study With Prospective Follow-Up (HARMOny Study). JMIR research protocols 10 (1) (2021)
Mary E Velthuizen, Rob B van der Luijt, Beja J de Vries, Marco J Koudijs, Eveline M A Bleiker, Margreet G E M Ausems
Recontacting non-BRCA1/2 breast cancer patients for germline CHEK2 c.1100del pathogenic variant testing: uptake and patient experiences. Hereditary cancer in clinical practice 19 (1) (2021)
Kasper Alexander Overbeek, Iris J M Levink, Brechtje D M Koopmann, Femme Harinck, Ingrid C A W Konings, Margreet G E M Ausems, Anja Wagner, Paul Fockens, Casper H J van Eijck, Bas Groot Koerkamp, Olivier R C Busch, Marc G H Besselink, Barbara A J Bastiaansen, Lydi M J W van Driel, Nicole Stephanie Erler, Frank P Vleggaar, Jan-Werner Poley, Djuna L Cahen, Jeanin E van Hooft, Marco J Bruno, null null
Long-term yield of pancreatic cancer surveillance in high-risk individuals. Gut (2021)
Jeanine van der Giessen, Mirjam P Fransen, Peter Spreeuwenberg, Mary Velthuizen, Sandra van Dulmen, Margreet G E M Ausems
Communication about breast cancer genetic counseling with patients with limited health literacy or a migrant background: evaluation of a training program for healthcare professionals. Journal of community genetics 12 (1) (2020)
Danny A Young-Afat, Carla Henrica van Gils, David J Bruinvels, Carmen C van der Pol, Arjen J Witkamp, Sieta Sijtsema, Yvette Jonasse, Rhodé M Bijlsma, Margreet G E M Ausems, Annelies M E Bos, Desirée H van den Bongard, Helena M Verkooijen
Patients' and Health Care Providers' Opinions on a Supportive Health App During Breast Cancer Treatment: A Qualitative Evaluation. JMIR cancer 2 (1) (2016)